Battling Skin Cancer? Look No Further than the Non-Surgical SRT-100™ for Your Squamous Cell Carcinoma Treatment
Squamous cell carcinoma is the second most common type of skin cancer, with more than 700,000 new cases diagnosed each year in the United States.
Squamous cell carcinoma develops in the thin, flat squamous cells that make up the outer layer of the skin. Squamous cells are found all over the body, and this type of cancer can occur anywhere squamous cells are found. Though this form of skin cancer is not usually life threatening, in some cases, it can be aggressive and if left untreated can spread to other parts of your body.
In most cases, squamous cell carcinoma is the result of prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds or lamps. People who have fair skin, a history of sunburns, a personal history of precancerous skin lesions or skin cancer, or a weakened immune system may be at increased risk of developing this type of cancer.
Squamous cell carcinoma treatment depends on the size, location and aggressiveness of the tumor. In many cases, treatment requires invasive procedures that can damage healthy tissue, cause painful healing, result in a lengthy recovery and leave unsightly scarring that can even take a toll on your emotions.
Sensus Healthcare’s SRT-100™ is a new, non-surgical approach to squamous cell carcinoma treatment. The SRT-100™ delivers a precise, calibrated dose of Superficial Radiotherapy directly to the affected squamous cells, destroying the cancer cells without damaging surrounding tissue. Superficial Radiotherapy with the SRT-100™ is safe and effective, and involves no cutting, bleeding or stitching. If your doctor uses the SRT-100™ for treatment of your squamous cell carcinoma, you will not need to go under general anesthesia, and there is no risk for infection or scarring and no need for reconstructive plastic surgery after surgery. Patients who undergo treatment with the SRT-100™ heal quickly, with no downtime or lifestyle restrictions following treatment.
For patients battling skin cancer, the SRT-100™ has cure rates comparable to those of surgical squamous cell carcinoma treatment options. If you have health risks that may prevent you from undergoing surgical treatment, or you wish to avoid the pain and scarring associated with surgery, talk to your doctor about Superficial Radiotherapy with the SRT-100™. For more information or to find an SRT-100™ physician near you, contact us today.